Pall Corporation, an operating company within Danaher Corporation’s Life Sciences platform filtration, separation and purification technologies, has finalized a shareholding acquisition of Pall-Austar Lifesciences Limited, a joint venture (JV) established by Pall and Austar. This acquisition will expand manufacturing capacity to primarily support single-use technology supply chain demand in China, driven by COVID-19.
The COVID-19 pandemic triggered a surge in demand for products that support vaccine manufacture scale-up. The Pall-Austar JV acquisition directly addresses this challenge by expanding Pall’s single-use technology manufacturing capabilities in China, which will increase output and reduce lead time for critical biopharmaceutical solutions.
Joseph Repp, President, Pall Life Sciences, said: “We have seen enormous increases in demand to support vaccine and therapeutic development. The Pall-Austar JV acquisition is an important step in our global capacity expansion plan and will help customers reduce production time, increase efficacy and improve productivity.”
Bing Li, President, Danaher China Life Sciences platform, said: “Our acquisition of Pall-Austar JV will equip us with localized manufacturing capability on single-use products based in China. It is another step forward for the Danaher Life Sciences platform by building in-country operations. We see this acquisition as an important milestone to realize Pall’s aspiration to become a truly localized enterprise dedicated to Chinese customers.”
Pall has invested $114M to expand global production capacity for critical biopharma products that support the development of COVID-19 vaccines and other life saving vaccines and therapies. This acquisition is the next phase in Pall’s plans to better serve the biopharma industry in China and around the world.
About Pall Corporation
Pall Corporation is a filtration, separation and purification leader providing solutions to meet the critical fluid management needs of customers across the broad spectrum of life sciences and industry. Pall works with customers to advance health, safety and environmentally responsible technologies. The Company’s engineered products enable process and product innovation and minimize emissions and waste. Pall Corporation serves customers worldwide. For more information visit www.pall.com.
El equipo de investigadores observó cambios en el...
El gen AtCDF3 promueve una mayor producción de az...
Un estudio con datos de los últimos 35 años, ind...
En nuestro post hablamos sobre este interesante tipo de célula del si...
Investigadores del Cima Universidad de Navarra constatan que la combin...
